We are live on ! Find out more

2,981 hedge funds and large institutions have $106B invested in Pfizer in 2026 Q1 according to their latest regulatory filings, with 259 funds opening new positions, 1,316 increasing their positions, 1,098 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

301% more capital inflows, than outflows

Capital inflows: $20.9B | Capital outflows: $5.2B

52% more first-time investments, than exits

New positions opened: 259 | Existing positions closed: 170

52% more funds holding in top 10

Funds holding in top 10: 31 → 47 (+16)

20% more repeat investments, than reductions

Existing positions increased: 1,316 | Existing positions reduced: 1,098

15% more call options, than puts

Call options by funds: $3.08B | Put options by funds: $2.68B

2% more funds holding

Funds holding: 2,936 → 2,981 (+45)

0.57% more ownership

Funds ownership: 65.62% → 66.19% (+0.57%)

Holders
2,981
Holders Change
+45
Holders Change %
+1.53%
% of All Funds
36.16%
Holding in Top 10
47
Holding in Top 10 Change
+16
Holding in Top 10 Change %
+51.61%
% of All Funds
0.57%
New
259
Increased
1,316
Reduced
1,098
Closed
170
Calls
$3.08​B
Puts
$2.68​B
Net Calls
+$400​M
Net Calls Change
+$993​M

PFE Hedge Fund Activity: Q1 2026 in Review

2,981 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2026, worth a combined $106B — up 14% from $92.9B a quarter earlier.

Buyers outnumbered sellers: 259 funds opened new PFE positions and 170 closed out — a net gain of 89 holders — while 1,316 added to existing stakes and 1,098 trimmed.

The largest buyer was Fisher Asset Management, adding an estimated $1.41B. The largest seller was BNP Paribas Financial Markets, cutting an estimated $176M.

  • 2,981 institutional investors held Pfizer (PFE) as of Q1 2026, up from 2,936 in Q4 2025.
  • Funds reported $106B of Pfizer stock for Q1 2026, up 14% quarter-over-quarter.
  • 259 funds opened new Pfizer positions in Q1 2026 and 170 closed out, a net change of +89 holders.
  • The largest Pfizer buyer in Q1 2026 was Fisher Asset Management, an estimated $1.41B added.
  • The largest Pfizer seller in Q1 2026 was BNP Paribas Financial Markets, an estimated $176M sold.

Based on aggregated 13F filings for Q1 2026.